Academics plea for politicians to tackle problem of missing dataBMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e7306 (Published 29 October 2012) Cite this as: BMJ 2012;345:e7306
- Zosia Kmietowicz
Campaigners have called on the government to take action to end the “ongoing secrecy” that surrounds the reporting of clinical trials.
In a letter to the Times they write that despite drug companies being required by law to report negative as well as positive results from clinical trials, the reality is somewhat different.1
“We wish that drug companies truly were compelled to be transparent. In reality, vitally important information about drug trials continues to be …